1 association of cfi p.gly119arg gene polymorphism with age-related macular degeneration (amd) disease in the population living in tehran

2 Optical Coherence Tomography-Based Deep-Learning Models for Classifying Normal and Age-Related Macular Degeneration and Exudative and Non-Exudative Age-Related Macular Degeneration Changes.

3 Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

4 Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

5 Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

6 Targeting modifiable risk factors in age-related macular degeneration in optometric practice in Sweden

7 Congenital hepatic fibrosis and coexistent retinal macular degeneration: A case report.

8 Interactome Mapping Guided by Tissue-Specific Phosphorylation in Age-Related Macular Degeneration.

9 Computer-based detection of age-related macular degeneration and glaucoma using retinal images and clinical data

10 Polarization Variability in Age-related Macular Degeneration.

11 Relationship between HTRA1 polymorphism and genetic susceptibility of wet age-related macular degeneration in Han population

12 Influence of mydriasis on optical coherence tomography angiography imaging in patients with age-related macular degeneration.

13 Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration.

14 Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

15 Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?

16 StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.

17 Near-Infrared Reflectance Imaging for Quantification of Atrophy associated with Age-related Macular Degeneration.

18 Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration.

19 [A differentiated approach to analysis of retinal fluid and assessment of its effect on anti-VEGF therapy of neovascular age-related macular degeneration].

20 Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?

21 Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration.

22 Retinal Spectral Domain Optical Coherence Tomography in Early Atrophic Age-Related Macular Degeneration (AMD) and a New Metric for Objective Evaluation of the Efficacy of Ocular Nutrition

23 Effects of Retinal Morphology on Contrast Sensitivity and Reading Ability in Neovascular Age-Related Macular Degeneration

24 Retinal-image quality and contrast-sensitivity function in age-related macular degeneration

25 Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration

26 Simple Estimation of Clinically Relevant Lesion Volumes Using Spectral Domain–Optical Coherence Tomography in Neovascular Age-Related Macular Degeneration

27 Effects of Retinal Morphology on Contrast Sensitivity and Reading Ability in Neovascular Age-Related Macular Degeneration

28 Contrast Sensitivity Evaluation in Eyes Predisposed to Age-Related Macular Degeneration and Presenting Normal Visual Acuity

29 Prevention of age related macular degeneration

30 Following the Status of Visual Cortex Over Time in Patients With Macular Degeneration Reveals Atrophy of Visually Deprived Brain Regions

31 Contrast sensitivity evaluation in eyes predisposed to age-related macular degeneration and presenting normal visual acuity

32 Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration as First Choice: a New Italian Ruling

33 cGAS drives noncanonical-inflammasome activation in age-related macular degeneration

34 Visual Performance in Patients with Neovascular Age-Related Macular Degeneration Undergoing Treatment with Intravitreal Ranibizumab

35 Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab

36 intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade

37 age-related macular degeneration in a randomized controlled trial of low-dose aspirin: rationale and study design of the aspree-amd study

38 ranibizumab with transpupillary thermotherapy for clinical efficacy in wet age-related macular degeneration

39 plasma metabolomic study in chinese patients with wet age-related macular degeneration

40 avaliação da perimetria macular em pacientes com degeneração macular relacionada à idade por meio do oftalmoscópio de rastreamento a laser evaluation of macular perimetry in patients with age-related macular degeneration using the scanning laser ophthalmoscope

41 clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation

42 role of factor h and related proteins in regulating complement activation in the macula, and relevance to age-related macular degeneration

43 age-related macular degeneration: advances in management and diagnosis

44 sd-oct morphological changes in wet age-related macular degeneration patients after bevacizumab treatment

45 long-lasting effects of anti-vegf/photodynamic combination therapy in the treatment of exudative age-related macular degeneration: a retrospective chart review

46 role of the choroid in age-related macular degeneration: a current review

47 association of obesity and age-related macular degeneration in indian population

48 successful treatment of neovascular age-related macular degeneration following single bevacizumab failure using aflibercept in a vitrectomized eye

49 treatment of retinal pigment epithelial detachment secondary to exudative age-related macular degeneration

50 progress and perspectives on the role of rpe cell inflammatory responses in the development of age-related macular degeneration

51 european survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the age-related eye disease study

52 choice of cell source in cell-based therapies for retinal damage due to age-related macular degeneration: a review

53 new approaches in the management of choroidal neovascular membrane in age-related macular degeneration.

54 prognostic factors of early morphological response to treatment with ranibizumab in patients with wet age-related macular degeneration

55 efficacy of vitrectomy and epiretinal membrane peeling in eyes with dry age-related macular degeneration

56 lifestyle risk factors associated with age-related macular degeneration

57 automatic screening and grading of age-related macular degeneration from texture analysis of fundus images

58 long-term visual outcome in wet age-related macular degeneration patients depending on the number of ranibizumab injections

59 blockade of tumor necrosis factor-alpha: a role for adalimumab in neovascular age-related macular degeneration refractory to anti-angiogenesis therapy

60 oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration

61 melatonin in retinal physiology and pathology: the case of age-related macular degeneration

62 preservation of the photoreceptor inner/outer segment junction in dry age-related macular degeneration treated by rheohemapheresis

63 visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population

64 c-reactive protein as a mediator of complement activation and inflammatory signaling in age-related macular degeneration

65 Outcomes in the Treatment of Subretinal Macular Hemorrhage Secondary to Age-Related Macular Degeneration: A Systematic Review.

Keyword Connections

Journals

Research Groups

Bibliographies